No abstract available
MeSH terms
-
Aged
-
Antibodies, Monoclonal / immunology
-
Antibodies, Monoclonal / therapeutic use*
-
Antineoplastic Agents / immunology
-
Antineoplastic Agents / therapeutic use*
-
B7-H1 Antigen / genetics*
-
B7-H1 Antigen / immunology
-
Carcinoma, Non-Small-Cell Lung / immunology
-
Carcinoma, Non-Small-Cell Lung / mortality
-
Carcinoma, Non-Small-Cell Lung / therapy*
-
Clinical Trials as Topic
-
Drug Administration Schedule
-
Female
-
Gene Expression
-
Humans
-
Immunoglobulin G / immunology
-
Immunotherapy*
-
Lung Neoplasms / immunology
-
Lung Neoplasms / mortality
-
Lung Neoplasms / therapy*
-
Middle Aged
-
Molecular Targeted Therapy
-
Nivolumab
-
Programmed Cell Death 1 Receptor / antagonists & inhibitors*
-
Programmed Cell Death 1 Receptor / genetics
-
Programmed Cell Death 1 Receptor / immunology
-
Survival Analysis
Substances
-
Antibodies, Monoclonal
-
Antineoplastic Agents
-
B7-H1 Antigen
-
CD274 protein, human
-
Immunoglobulin G
-
PDCD1 protein, human
-
Programmed Cell Death 1 Receptor
-
Nivolumab